{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:57:59Z","timestamp":1791413879927,"version":"4.3.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2012,4,5]],"date-time":"2012-04-05T00:00:00Z","timestamp":1333584000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s00415-012-6478-6","type":"journal-article","created":{"date-parts":[[2012,4,4]],"date-time":"2012-04-04T09:42:27Z","timestamp":1333532547000},"page":"2167-2171","source":"Crossref","is-referenced-by-count":68,"title":["Characteristics of late-onset myasthenia gravis"],"prefix":"10.1007","volume":"259","author":[{"given":"Sa\u0161a A.","family":"\u017divkovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula R.","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lacomis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,5]]},"reference":[{"key":"6478_CR1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","volume":"8","author":"MN Meriggioli","year":"2009","unstructured":"Meriggioli MN, Sanders DB (2009) Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 8:475\u2013490","journal-title":"Lancet Neurol"},{"key":"6478_CR2","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/jnnp.74.8.1105","volume":"74","author":"A Vincent","year":"2003","unstructured":"Vincent A, Clover L, Buckley C, Grimley Evans J, Rothwell PM (2003) Evidence of underdiagnosis of myasthenia gravis in older people. J Neurol Neurosurg Psychiatry 74:1105\u20131108","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6478_CR3","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1212\/01.WNL.0000050461.05432.C5","volume":"60","author":"JM Aragones","year":"2003","unstructured":"Aragones JM, Bolibar I, Bonfill X, Bufill E, Mummany A, Alonso F et al (2003) Myasthenia gravis: a higher than expected incidence in the elderly. Neurology 60:1024\u20131026","journal-title":"Neurology"},{"key":"6478_CR4","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1196\/annals.1405.040","volume":"1132","author":"JA Aarli","year":"2008","unstructured":"Aarli JA (2008) Myasthenia gravis in the elderly: is it different? Ann NY Acad Sci 1132:238\u2013243","journal-title":"Ann NY Acad Sci"},{"key":"6478_CR5","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1212\/WNL.47.5.1233","volume":"47","author":"LH Phillips 2nd","year":"1996","unstructured":"Phillips LH 2nd, Torner JC (1996) Epidemiologic evidence for a changing natural history of myasthenia gravis. Neurology 47:1233\u20131238","journal-title":"Neurology"},{"key":"6478_CR6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mus.22006","volume":"44","author":"JT Guptill","year":"2011","unstructured":"Guptill JT, Sanders DB, Evoli A (2011) Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts. Muscle Nerve 44:36\u201340","journal-title":"Muscle Nerve"},{"key":"6478_CR7","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1212\/WNL.40.5.786","volume":"40","author":"DH Donaldson","year":"1990","unstructured":"Donaldson DH, Ansher M, Horan S, Rutherford RB, Ringel SP (1990) The relationship of age to outcome in myasthenia gravis. Neurology 40:786\u2013790","journal-title":"Neurology"},{"key":"6478_CR8","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1212\/WNL.42.10.1888","volume":"42","author":"LH Phillips 2nd","year":"1992","unstructured":"Phillips LH 2nd, Torner JC, Anderson MS, Cox GM (1992) The epidemiology of myasthenia gravis in central and western Virginia. Neurology 42:1888\u20131893","journal-title":"Neurology"},{"key":"6478_CR9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/ageing\/25.1.56","volume":"25","author":"F Schon","year":"1996","unstructured":"Schon F, Drayson M, Thompson RA (1996) Myasthenia gravis and elderly people. Age Ageing 25:56\u201358","journal-title":"Age Ageing"},{"key":"6478_CR10","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1749-6632.1998.tb11017.x","volume":"841","author":"G Slesak","year":"1998","unstructured":"Slesak G, Melms A, Gerneth F, Sommer N, Weissert R, Dichgans J (1998) Late-onset myasthenia gravis. Follow-up of 113 patients diagnosed after age 60. Ann NY Acad Sci 841:777\u2013780","journal-title":"Ann NY Acad Sci"},{"key":"6478_CR11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archneur.56.1.25","volume":"56","author":"JA Aarli","year":"1999","unstructured":"Aarli JA (1999) Late-onset myasthenia gravis: a changing scene. Arch Neurol 56:25\u201327","journal-title":"Arch Neurol"},{"key":"6478_CR12","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1212\/01.wnl.0000176067.32186.a3","volume":"65","author":"FE Somnier","year":"2005","unstructured":"Somnier FE (2005) Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis. Neurology 65:928\u2013930","journal-title":"Neurology"},{"key":"6478_CR13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mus.20950","volume":"37","author":"D Grob","year":"2008","unstructured":"Grob D, Brunner N, Namba T, Pagala M (2008) Lifetime course of myasthenia gravis. Muscle Nerve 37:141\u2013149","journal-title":"Muscle Nerve"},{"key":"6478_CR14","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1590\/S0004-282X2010000600003","volume":"68","author":"A Aguiar Ade","year":"2010","unstructured":"Aguiar Ade A, Carvalho AF, Costa CM, Fernandes JM, D\u2019Almeida JA, Furtado LE et al (2010) Myasthenia gravis in Ceara, Brazil: clinical and epidemiological aspects. Arq Neuropsiquiatr 68:843\u2013848","journal-title":"Arq Neuropsiquiatr"},{"key":"6478_CR15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1196\/annals.1254.054","volume":"998","author":"R Mantegazza","year":"2003","unstructured":"Mantegazza R, Baggi F, Antozzi C, Confalonieri P, Morandi L, Bernasconi P et al (2003) Myasthenia gravis (MG): epidemiological data and prognostic factors. Ann NY Acad Sci 998:413\u2013423","journal-title":"Ann NY Acad Sci"},{"key":"6478_CR16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jns.2011.03.004","volume":"305","author":"H Murai","year":"2011","unstructured":"Murai H, Yamashita N, Watanabe M, Nomura Y, Motomura M, Yoshikawa H et al (2011) Characteristics of myasthenia gravis according to onset-age: Japanese nationwide survey. J Neurol Sci 305:97\u2013102","journal-title":"J Neurol Sci"},{"key":"6478_CR17","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4103\/0028-3886.43455","volume":"56","author":"BS Singhal","year":"2008","unstructured":"Singhal BS, Bhatia NS, Umesh T, Menon S (2008) Myasthenia gravis: a study from India. Neurol India 56:352\u2013355","journal-title":"Neurol India"},{"key":"6478_CR18","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1212\/WNL.0b013e3181a41211","volume":"72","author":"A Alshekhlee","year":"2009","unstructured":"Alshekhlee A, Miles JD, Katirji B, Preston DC, Kaminski HJ (2009) Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals. Neurology 72:1548\u20131554","journal-title":"Neurology"},{"key":"6478_CR19","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/mus.1139","volume":"24","author":"AAEM Quality Assurance Committee","year":"2001","unstructured":"AAEM Quality Assurance Committee (2001) Practice parameter for repetitive nerve stimulation and single fiber EMG evaluation of adults with suspected myasthenia gravis or Lambert\u2013Eaton myasthenic syndrome: summary statement. Muscle Nerve 24:1236\u20131238","journal-title":"Muscle Nerve"},{"key":"6478_CR20","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2337\/dc06-0062","volume":"29","author":"CC Cowie","year":"2006","unstructured":"Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau MM et al (2006) Prevalence of diabetes and impaired fasting glucose in adults in the US population: National Health and Nutrition Examination Survey 1999\u20132002. Diabetes Care 29:1263\u20131268","journal-title":"Diabetes Care"},{"key":"6478_CR21","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/(SICI)1097-4598(199909)22:9<1297::AID-MUS22>3.0.CO;2-C","volume":"22","author":"LH Phillips 2nd","year":"1999","unstructured":"Phillips LH 2nd, Juel VC (1999) Myasthenia gravis in the tenth decade. Muscle Nerve 22:1297\u20131298","journal-title":"Muscle Nerve"},{"key":"6478_CR22","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/jnnp.2006.100545","volume":"78","author":"X Zhang","year":"2007","unstructured":"Zhang X, Yang M, Xu J, Zhang M, Lang B, Wang W et al (2007) Clinical and serological study of myasthenia gravis in HuBei Province, China. J Neurol Neurosurg Psychiatry 78:386\u2013390","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6478_CR23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clim.2003.10.004","volume":"110","author":"N Shinomiya","year":"2004","unstructured":"Shinomiya N, Nomura Y, Segawa M (2004) A variant of childhood-onset myasthenia gravis: HLA typing and clinical characteristics in Japan. Clin Immunol 110:154\u2013158","journal-title":"Clin Immunol"},{"key":"6478_CR24","doi-asserted-by":"crossref","first-page":"6067","DOI":"10.4049\/jimmunol.0901618","volume":"184","author":"S Stacy","year":"2010","unstructured":"Stacy S, Williams EL, Standifer NE, Pasquali A, Krolick KA, Infante AJ et al (2010) Maintenance of immune tolerance to a neo-self acetylcholine receptor antigen with aging: implications for late-onset autoimmunity. J Immunol 184:6067\u20136075","journal-title":"J Immunol"},{"key":"6478_CR25","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1053\/berh.2002.0257","volume":"16","author":"DP Symmons","year":"2002","unstructured":"Symmons DP (2002) Epidemiology of rheumatoid arthritis: determinants of onset, persistence and outcome. Best Pract Res Clin Rheumatol 16:707\u2013722","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"6478_CR26","unstructured":"US Census Bureau (2011) Census 2009: Quickfacts. http:\/\/quickfacts.census.gov\/qfd\/states\/42000.html . Accessed on 29 Sept 2011"},{"key":"6478_CR27","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2165\/11316480-000000000-00000","volume":"26","author":"DR Kuypers","year":"2009","unstructured":"Kuypers DR (2009) Immunotherapy in elderly transplant recipients: a guide to clinically significant drug interactions. Drugs Aging 26:715\u2013737","journal-title":"Drugs Aging"},{"key":"6478_CR28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1744-9987.2009.00793.x","volume":"14","author":"N Basic-Jukic","year":"2010","unstructured":"Basic-Jukic N, Brunetta B, Kes P (2010) Plasma exchange in elderly patients. Ther Apher Dial 14:161\u2013165","journal-title":"Ther Apher Dial"},{"key":"6478_CR29","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1517\/14740338.2010.484419","volume":"9","author":"JB Caress","year":"2010","unstructured":"Caress JB, Kennedy BL, Eickman KD (2010) Safety of intravenous immunoglobulin treatment. Expert Opin Drug Saf 9:971\u2013979","journal-title":"Expert Opin Drug Saf"},{"key":"6478_CR30","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1212\/WNL.48.5.1253","volume":"48","author":"CE Thomas","year":"1997","unstructured":"Thomas CE, Mayer SA, Gungor Y, Swarup R, Webster EA, Chang I et al (1997) Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation. Neurology 48:1253\u20131260","journal-title":"Neurology"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-012-6478-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-012-6478-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-012-6478-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:23:01Z","timestamp":1559056981000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-012-6478-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,5]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["6478"],"URL":"https:\/\/doi.org\/10.1007\/s00415-012-6478-6","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,5]]}}}